Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Molecular Chaperones and Protein Folding

Molecular Chaperones and Protein Folding

The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...

Molecular Chaperones and Protein Folding

Molecular Chaperones and Protein Folding

Protein Folding

Protein Folding

Proteins are chains of amino acids linked together by peptide bonds. Upon synthesis, a protein folds into a three-dimensional conformation, critical to its biological function. Interactions between its constituent amino acids guide protein folding, and hence the protein structure is primarily dependent on its amino acid sequence.
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...

Protein Folding

Protein Folding

Protein Folding

Protein Folding

Export of Misfolded Proteins out of the ER

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Ion channel, CFTR, assembles with HIPPO pathway proteins TAZ and YAP in polycystic kidney disease.

The Journal of biological chemistry·2026

Same author

A novel gene therapy for ARPKD based on CFTR.

American journal of physiology. Gastrointestinal and liver physiology·2025

Same author

AAV1-CFTR preferentially transduces cysts and reduces cyst size in a mouse model of ADPKD.

American journal of physiology. Cell physiology·2025

Same author

Amelioration of airway and GI disease in G551D-CF ferrets by AAV1 and AAV6.

Gene therapy·2024

Same author

Transduction of Ferret Surface and Basal Cells of Airways, Lung, Liver, and Pancreas via Intratracheal or Intravenous Delivery of Adeno-Associated Virus 1 or 6.

Human gene therapy·2023

Same author

CFTR and PC2, partners in the primary cilia in autosomal dominant polycystic kidney disease.

American journal of physiology. Cell physiology·2023

Search research articles

Related Experiment Video

Updated: Apr 27, 2026

Analysis of Protein Folding, Transport, and Degradation in Living Cells by Radioactive Pulse Chase

Analysis of Protein Folding, Transport, and Degradation in Living Cells by Radioactive Pulse Chase

Published on: February 12, 2019

Complement yourself: Transcomplementation rescues partially folded mutant proteins.

Liudmila Cebotaru¹, William B Guggino²

¹Department of Ophthalmology, School of Medicine, The Johns Hopkins University, Baltimore, MD 21205 ; Department of Physiology, School of Medicine, The Johns Hopkins University, Baltimore, MD 21205.

Biophysical Reviews

|June 21, 2014

Summary

Novel transcomplementation therapy shows promise for Cystic Fibrosis (CF). Co-expressing CFTR fragments with the common ΔF508 mutation rescues protein function and reduces degradation in airway cells.

More Related Videos

Examining Proteasome Assembly with Recombinant Archaeal Proteasomes and Nondenaturing PAGE: The Case for a Combined Approach

Examining Proteasome Assembly with Recombinant Archaeal Proteasomes and Nondenaturing PAGE: The Case for a Combined Approach

Published on: December 17, 2016

Assays for the Degradation of Misfolded Proteins in Cells

Assays for the Degradation of Misfolded Proteins in Cells

Published on: August 28, 2016

Related Experiment Videos

Last Updated: Apr 27, 2026

Analysis of Protein Folding, Transport, and Degradation in Living Cells by Radioactive Pulse Chase

Analysis of Protein Folding, Transport, and Degradation in Living Cells by Radioactive Pulse Chase

Published on: February 12, 2019

Examining Proteasome Assembly with Recombinant Archaeal Proteasomes and Nondenaturing PAGE: The Case for a Combined Approach

Examining Proteasome Assembly with Recombinant Archaeal Proteasomes and Nondenaturing PAGE: The Case for a Combined Approach

Published on: December 17, 2016

Assays for the Degradation of Misfolded Proteins in Cells

Assays for the Degradation of Misfolded Proteins in Cells

Published on: August 28, 2016

Area of Science:

Molecular Biology
Genetics
Cell Biology

Background:

Cystic Fibrosis (CF) is a genetic disorder affecting fluid and electrolyte transport.
The most common mutation, ΔF508, causes CFTR protein misfolding and dysfunction.
Current treatments manage symptoms but do not address the underlying protein defect.

Purpose of the Study:

To explore transcomplementation as a novel therapeutic strategy for CF.
To investigate the rescue of ΔF508-CFTR protein processing and function.
To assess the potential of gene therapy for delivering corrective CFTR fragments.

Main Methods:

Co-expression of wild-type CFTR fragments with the ΔF508 mutant.
Analysis of CFTR protein processing and degradation in airway epithelial cells.
Evaluation of adeno-associated viral vectors for gene delivery.

Main Results:

Transcomplementation successfully rescued ΔF508-CFTR processing and channel activity.
Co-expression reduced the degradation rate of the ΔF508 mutant protein.
Gene therapeutic approaches using viral vectors are feasible for delivering truncated CFTR.

Conclusions:

Transcomplementation offers a promising approach to restore CFTR function in CF.
Gene therapy with viral vectors is a viable strategy for delivering therapeutic CFTR fragments.
This strategy could lead to new treatments for Cystic Fibrosis.